About Surgical Innovations (LON:SUN)
Surgical Innovations Group plc designs, develops, manufactures, and sells medical devices for use in minimally invasive surgery and precision engineering markets. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Precision Engineering (PE). The SI Brand segment researches, develops, manufactures, and distributes minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. The OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label, or co-branding. This segment also provides design and development solutions for producing a final device. The PE segment researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was founded in 1992 and is based in Leeds, the United Kingdom.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolLON:SUN
CUSIPN/A
Phone+44-113-2307597
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins8.68%
Return on Equity9.99%
Return on Assets8.63%
Miscellaneous
EmployeesN/A
Outstanding Shares782,360,000
Surgical Innovations (LON:SUN) Frequently Asked Questions
What is Surgical Innovations' stock symbol?
Surgical Innovations trades on the London Stock Exchange (LON) under the ticker symbol "SUN."
What price target have analysts set for SUN?
1 equities research analysts have issued 1-year price targets for Surgical Innovations' stock. Their forecasts range from GBX 5.50 to GBX 5.50. On average, they expect Surgical Innovations' stock price to reach GBX 5.50 in the next twelve months. View Analyst Ratings for Surgical Innovations.
Who are some of Surgical Innovations' key competitors?
Some companies that are related to Surgical Innovations include Navidea Biopharmaceuticals (NAVB), Arcturus Therapeutics (ARCT), Scynexis (SCYX), Obalon Therapeutics (OBLN), Five Star Senior Living (FVE), Versartis (VSAR), Pain Therapeutics (PTIE), BioSig Technologies (BSGM), Catabasis Pharmaceuticals (CATB), Rexahn Pharmaceuticals (RNN), Zosano Pharma (ZSAN), TRACON Pharmaceuticals (TCON), Abzena (ABZA), Scancell (SCLP), Immutep (IMMP), CytRx (CYTR), VolitionRX (VNRX) and Novus Therapeutics (NVUS).
Who are Surgical Innovations' key executives?
Surgical Innovations' management team includes the folowing people:
- Mr. Nigel F. Rogers FCA, Exec. Chairman (Age 56)
- Mrs. Melanie Ross, Chief Financial Officer, Chief Operating Officer and Director (Age 38)
- Mr. Adam Power, Group Devel. Director & Director
- Mr. David John Marsh, Group Commercial Director & Director
- Ms. Charmaine Day ACCA, Financial Controller and Company Sec. (Age 36)
Has Surgical Innovations been receiving favorable news coverage?
News headlines about SUN stock have been trending somewhat negative this week, Accern Sentiment reports. Accern ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Surgical Innovations earned a media sentiment score of -0.06 on Accern's scale. They also gave news coverage about the company an impact score of 47.37 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Surgical Innovations?
Shares of SUN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Surgical Innovations' stock price today?
One share of SUN stock can currently be purchased for approximately GBX 3.80.
How big of a company is Surgical Innovations?
Surgical Innovations has a market capitalization of £31.75 million.
How can I contact Surgical Innovations?
Surgical Innovations' mailing address is Clayton Wood House, 6 Clayton Wood Bank, LEEDS, LS16 6QZ, United Kingdom. The company can be reached via phone at +44-113-2307597.
MarketBeat Community Rating for Surgical Innovations (SUN)
MarketBeat's community ratings are surveys of what our community members think about Surgical Innovations and other stocks. Vote "Outperform" if you believe SUN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SUN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Surgical Innovations (LON:SUN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Surgical Innovations in the last 12 months. Their average twelve-month price target is GBX 5.50The high price target for SUN is GBX 5.50 and the low price target for SUN is GBX 5.50. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | GBX 5.50 | GBX 5.50 | GBX 5.50 | GBX 5.50 |
Surgical Innovations (LON:SUN) Consensus Price Target History
Surgical Innovations (LON:SUN) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 9/13/2017 | N+1 Singer | Reiterated Rating | Buy | |  |
(Data available from 4/20/2016 forward)
Surgical Innovations (LON:SUN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Surgical Innovations (LON SUN) Insider Trading and Institutional Ownership History
Surgical Innovations (LON SUN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/23/2018 | Melanie Ross | Insider | Buy | 504,644 | GBX 4 | £20,185.76 | | |
| 3/13/2018 | Nigel Rogers | Insider | Buy | 902,584 | GBX 4 | £36,103.36 | | |
| 12/21/2017 | Michael John McMahon | Insider | Buy | 82,759 | GBX 4 | £3,310.36 | | |
| 11/10/2017 | Adam Power | Insider | Buy | 29,690 | GBX 3 | £890.70 | | |
| 11/3/2017 | Charmaine Day | Insider | Buy | 305,343 | GBX 3 | £9,160.29 | | |
| 10/31/2017 | Nigel Rogers | Insider | Buy | 500,000 | GBX 3 | £15,000 | | |
| 9/27/2017 | Adam Power | Insider | Buy | 27,612 | GBX 4 | £1,104.48 | | |
| 7/27/2017 | Paul Hardy | Insider | Buy | 815,721 | GBX 3 | £24,471.63 | | |
| 4/10/2017 | Alistair Taylor | Insider | Buy | 401,360 | GBX 4 | £16,054.40 | | |
| 3/31/2017 | Melanie Ross | Insider | Buy | 265,000 | GBX 6 | £15,900 | | |
| 3/27/2017 | Paul Hardy | Insider | Buy | 814,000 | GBX 4 | £32,560 | | |
| 11/1/2016 | Nigel Rogers | Insider | Buy | 480,000 | GBX 3 | £14,400 | | |
| 9/30/2016 | Paul Hardy | Insider | Buy | 210,526 | GBX 2 | £4,210.52 | | |
| 6/27/2016 | Taylor,Alistair | Insider | Buy | 176,471 | GBX 2 | £3,529.42 | | |
| 5/26/2016 | Rogers,Nigel | Insider | Buy | 1,140,000 | GBX 2 | £22,800 | | |
| 3/21/2016 | Hardy,Paul | Insider | Buy | 750,000 | GBX 2 | £15,000 | | |
| 3/18/2016 | Hardy,Paul | Insider | Buy | 650,000 | GBX 2 | £13,000 | | |
| 10/29/2015 | Rogers,Nigel | Insider | Buy | 1,000,000 | GBX 1 | £10,000 | | |
| 10/28/2015 | Rogers,Nigel | Insider | Buy | 605,714 | GBX 2 | £12,114.28 | | |
(Data available from 1/1/2013 forward)
Surgical Innovations (LON SUN) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Surgical Innovations (SUN) Given Buy Rating at N+1 Singer
www.americanbankingnews.com - April 13 at 12:58 AM |
| Insider Buying: Surgical Innovations (SUN) Insider Buys 504,644 Shares of Stock
www.americanbankingnews.com - March 26 at 4:22 AM |
 | Surgical Innovations Confident In Outlook As Revenue Rises Sharply
www.morningstar.co.uk - March 14 at 10:53 AM |
| Insider Buying: Surgical Innovations Group Plc (SUN) Insider Purchases 902,584 Shares of Stock
www.americanbankingnews.com - March 13 at 1:21 PM |
 | Global advanced wound care market expected to be driven by increasing incidence of diabetes coupled with chronic wounds
www.marketwatch.com - March 12 at 10:23 AM |
 | What Is Surgical Innovations Group plc’s (LON:SUN) Share Price Doing?
finance.yahoo.com - February 28 at 4:42 PM |
| Surgical Innovations Shares Rise As It Renews Microline Contract
www.morningstar.co.uk - February 28 at 9:42 AM |
 | ARMS Medical and Tissue Regenix BioSurgery Sign Exclusive Distributor Agreement for DermaPure ® Allograft with dCELL ® Technology
www.bizjournals.com - February 26 at 4:43 PM |
| Surgical Innovations Signs Supply Agreement With Bariatric Solutions
www.morningstar.co.uk - February 19 at 9:17 AM |
| Global Deep Brain Stimulation Devices Industry
www.bizjournals.com - February 6 at 4:37 PM |
| Surgical Innovations Shares Rise As 2017 Revenue To Grow Considerably
www.morningstar.co.uk - January 11 at 11:32 AM |
 | Aura Biosciences Completes $30 Million Series C Financing
www.businesswire.com - December 21 at 11:02 AM |
| Surgical Innovations Group Plc (SUN) Insider Purchases £3,310.36 in Stock
www.americanbankingnews.com - December 21 at 8:40 AM |
| Should You Expect Surgical Innovations Group plc (AIM:SUN) To Continue Delivering An ROE Of 14.82%?
finance.yahoo.com - November 29 at 11:08 AM |
| Why Surgical Innovations Group plc (AIM:SUN) Has Zero-Debt On Its Balance Sheet
finance.yahoo.com - November 15 at 12:37 PM |
| Surgical Innovations Group plc (SUN) Insider Acquires £1,104.48 in Stock
www.americanbankingnews.com - November 15 at 7:26 AM |
| Insider Buying: Surgical Innovations Group plc (SUN) Insider Purchases 29,690 Shares of Stock
www.americanbankingnews.com - November 15 at 7:26 AM |
| Surgical Innovations Group Plc (SUN) Insider Buys £9,160.29 in Stock
www.americanbankingnews.com - November 6 at 3:34 AM |
| Surgical Innovations Group Plc (SUN) Insider Acquires £15,000 in Stock
www.americanbankingnews.com - October 31 at 8:36 AM |
| Surgical Innovations Group Plc (SUN) Given Buy Rating at N+1 Singer
www.americanbankingnews.com - September 13 at 8:32 PM |
| Surgical Innovations Swings To Interim Profit, Trading "Satisfactory"
www.morningstar.co.uk - September 13 at 9:41 AM |
| Surgical Innovations Group Plc (LON:SUN) Insider Paul Hardy Buys 815,721 Shares
www.americanbankingnews.com - July 28 at 7:34 AM |
 | New Veterans Affairs Chief: A Hands-On, Risk-Taking ‘Standout’
www.nytimes.com - May 9 at 10:15 AM |
| Promise Healthcare CEO Honored with 2016 Excalibur Award
www.businesswire.com - May 3 at 6:17 PM |
| Hospital Lighting Market Worth 7.03 Billion USD by 2021
www.marketwatch.com - May 2 at 5:54 PM |
| Surgical Innovations Converts Loan Notes And Issues Shares (ALLISS)
www.morningstar.co.uk - December 21 at 8:01 AM |
| Half Year 2016 Surgical Innovations Group PLC Earnings Release - Before Market Open
biz.yahoo.com - August 31 at 11:54 AM |
| Surgical Innovations Expects Large Revenue Rise, Improved Gross Margin
www.morningstar.co.uk - June 27 at 10:59 AM |
| Full Year 2015 Surgical Innovations Group PLC Earnings Release - Before Market Open
biz.yahoo.com - March 16 at 7:07 AM |
 | Minimally Invasive Surgery Market to Expand at 10.50% CAGR by 2019; Driven by Technological Advancements: Transparency Market Research
globenewswire.com - January 21 at 12:32 PM |
Surgical Innovations (LON:SUN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Surgical Innovations (LON SUN) Stock Chart for Friday, April, 20, 2018
Loading chart…
